title: Clinicians adjust to latest ESA recommendations.
authors.forename: Kate
authors.initials: K
authors.lastname: Traynor
mesh_terms: D000068256:Darbepoetin alfa; D004305:Dose-Response Relationship, Drug; D004348:Drug Labeling; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use*; D006397:Hematinics / Q000008:administration & dosage / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D006397:Hematinics; D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D000068817:Epoetin Alfa